Arterijska krutost kao prediktivni faktor kardiovaskularnih oboljenja

REFERENCES

Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H. Clinical applications of arterial stiffness: Therapeutics and pharmacology. Am J Hypertens 2002; 15(5): 453–8.

Franck O. Die Elasticitat des Blutegefasse. Z Biol 1920; 46: 255–72.

Bramwell JC, Hill AV. The Velocity of the Pulse Wave in Man. Proc. Roy. Soc. Lond. (Biol.) 1922; 93: 298–306.

Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM 2002; 95(2): 67–74.

Safar ME, O'rourke MF. Arterial Stiffness in Hypertension. In: Safar ME, O'rourke MF, editors. Arterial Handbook of Hyper-tension Series. 1st ed. Amsterdam: Elsevier; 2006. p. 598.

Nichols WW, O'rourke MF. McDonald's Blood Flow in arterial stiffness, and during treatment of hypertension. Hypertension 2001; 38: 914–21.

Nichols WW, McDonald DA. Wave-velocity in the proximal aorta. Med Biol Eng 1972; 10(3): 327–35.

Boutouyrie P, Lacolley P, Girerd X, Beck L, Safar M, Laurent S. Sympathetic activation decreases medium-sized arterial com-pliance in humans. Am J Physiol 1994; 267(4 Pt 2): 1368–76.

Giannattasio C, Failla M, Lucchina S, Zazzeron C, Scotti V, Capra A, et al. Arterial stiffening influence of sympathetic nerve ac-tivity: Evidence from hand transplantation in humans. Hyper-tension 2005; 45(4): 608–11.

Paunović K, Stojanov V, Jakovljević B, Belojević G. Thoracic bioelectrical impedance assessment of the hemodynamic reactions to recorded road-traffic noise in young adults. Environ Res 2014; 129: 52–8.

Giannattasio C, Failla M, Stella ML, Mangoni AA, Turrini D, Carugo S, et al. Angiotensin-converting enzyme inhibition and radial artery compliance in patients with congestive heart fail-ure. Hypertension 1995; 26(3): 491–6.

Lovic D, Kallistratos MS, Poulimenos L, Skyrlas A, Stojanov V, Ja-kovljevic B, et al. Pulse wave velocity: retrospective analysis in a Balkan normotensive and hypertensive population: A study of 9923 patients. Angiology 2018; 69(1): 59–64.

Hoeks AP, Brands PJ, Smeets FA, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 1990; 16(2): 121–8.

Feistritzer HJ, Reinstadler SJ, Klug G, Kremser C, Seidner B, Esterhammer R, et al. Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity. PLoS One 2015; 10(1): e0116862.

Chirinos JA, Segers P, Gillebert TC, de Buyzere MI, van Daele CM, Khan ZA, et al. Central pulse pressure and its hemodynamic determinants in middle - aged adults with impaired fasting glucose and diabetes: The Asklepios study. Diabetes Care 2013; 36(8): 2359–65.

Struijker Boudier HA, Cohuet GM, Baumann M, Safar ME. The heart, macrocirculation and microcirculation in hypertension: a unifying hypothesis. J Hypertens Suppl 2003; 21(3): S19–23.

Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, et al. Clinical applications of arterial stiffness, Task Force III: Recommendations for user proce-dures. Am J Hypertens 2002; 15(5): 445–52.

Sarafidis PA, Georgianos PI, Karpetas A, Bikos A, Korelidou L, Tersi M, et al. Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients. Am J Nephrol 2014; 40(3): 242–50.

Gosse P, Lasserre R, Minifié C, Lemetayer P, Clementy J. Arterial stiffness evaluated by measurement of the QKD interval is an independent predictor of cardiovascular events. Am J Hyper-tens 2005; 18(4 Pt 1): 470–6.

Stojanov V, Saranovic M, Jakovijević B, Paunović K. Thoracic elec-trical bioimpedance in the follow-up of patients with cardi-ovascular disorders. Srp Arh Celok Lek 2005; 133(5–6): 297–302. (Serbian)

Stojanov V, Jakovljevic P. Use of thoracic bioelectric impedance in the assessment of hemodynamic parameters of the cardi-ovascular system. Vojnosanit Pregl 2005; 62(4): 311–5. (Ser-bian)

Peco-Antić A, Pejcić I, Stojanov V, Parezanović V, Kostić M. Ambu-latory blood pressure monitoring in chronic haemodialysis children with end-stage renal failure. Nephron 1996; 72(4): 73–40.

Protogerou AD, Argyris AA, Papaioannou TG, Kollias GE, Konstantonis GD, Nasothimiou E, et al. Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: The SAFAR study. J Hypertens 2014; 32(9): 1805–14.

Wassertheurer S, Baumann M. Assessment of systolic aortic pressure and its association to all cause mortality critically depends on waveform calibration. J Hypertens 2015; 33(9): 1884–8; discussion 1889.

Chirinos JA, Kips JG, Jacobs DR, Brumback L, Duprez DA, Kron-mal R, et al. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol 2012; 60(21): 2170–7.

Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al.. Expert consensus document on arterial stiff-ness: methodological issues and clinical applications. Eur Heart J 2006; 27(21): 2588–605.

Albaladejo P, Copie X, Boutouyrie P, Laloux B, Déclère AD, Smu-lyan H, et al. Heart rate, arterial stiffness, and wave reflections in paced patients. Hypertension 2001; 38(4): 949–52.

Lantelme P, Mestre C, Lievre M, Gressard A, Milon H. Heart rate: An important confounder of pulse wave velocity as-sessment. Hypertension 2002; 39(6): 1083–7.

Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, et al. Heart rate dependency of pulse pressure amplifica-tion and arterial stiffness. Am J Hypertens 2002; 15(1 Pt 1): 24–30.

McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46(9): 1753–60.

Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, et al. Aortic PWV in chronic kidney disease: A CRIC ancillary study. Am J Hypertens 2010; 23(3): 282–9.

Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005; 45(6): 1050–5.

Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H, Webb DJ, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002; 39(6): 1005–11.

Asmar RG, London GM, O'Rourke ME, Safar ME. REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001; 38(4): 922–6.

Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34(5): 1203–6.

Williams B, Lacy PS. Impact of heart rate on control aortic pressures and hemodynamics: Analysis from the CAFE (Con-duit Artery Function Evaluation) study. CAFE-Heart Rate. J Am Coll Cardiol 2009; 54(8): 705–13.

Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardi-ovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55(13): 1318–27.

Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37(5): 1236–41.

Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63(7): 636–46.

de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME. REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination pe-rindopril/indapamide in hypertensive subjects. J Hypertens 2004; 22(8): 1623–30.

Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicenter randomised controlled trial. Lancet 2005; 366(9489): 895–906.

Balkestein EJ, Aggel-Leijssen DP, Baak MA, Struijker-Boudier HA, Van Bortel LM. The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J. Hypertens 1999; 17(12 Pt 2): 1831–5.

Avolio AP, Clyde KM, Beard TC, Cooke HM, Ho KK, O'Rourke MF. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6(2): 166–9.

Sierksma A, Lebrun CE, van der Schouw YT, Grobbee DE, Lamberts SW, Hendriks HF, et al. Alcohol consumption in relation to aortic stiffness and aortic wave reflections: a cross-sectional study in healthy postmenopausal women. Arterioscler Thromb Vasc Biol 2004; 24(2): 342–8.

Manisty CH, Hughes AD. Meta-analysis of the comparative ef-fects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index. Br J Clin Pharmacol 2013; 75(1): 79–92.

Kampus P, Serg M, Kals J, Zagura M, Muda P, Karu K, et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 2011; 57(6): 1122–8.

Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: Prognostic sig-nificance for end-stage renal disease patients. Hypertension 2005; 45(4): 592–6.

Janić M, Lunder M, Sabovič M. Arterial stiffness and cardiovascular therapy. Biomed Res Int 2014; 2014: 621437.

Weiss W, Gohlisch C, Harsch-Gladisch C, Tölle M, Zidek W, Giet M. Oscillometric estimation of central blood pressure: Valida-tion of the Mobil-O-Graph in comparison with the Sphygmo-Cor device. Blood Press Monit 2012; 17(3): 128–31.

Mahmud A, Feely J. Arterial stiffness and the renin-angiotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst 2004; 5(3): 102–8.

Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 2012; 221(1): 18–33.

London GM, Asmar RG, O'Rourke MF, Safar ME. REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindo-pril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004; 43(1): 92–9.

Deary AJ, Schumann AL, Murfet H, Haydock S, Foo RS, Brown MJ. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with es-sential hypertension. Clin Sci (Lond) 2002; 103(5): 49–9.

Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359(9311): 995–1003.

Dickstein K, Kjekshus J. OPTIMAAL Steering Committee of the OPTIMAAL Study Group. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 2002; 360(9335): 752–60.

Ghiadoni L, Virdis A, Magagna A, Taddei S, Salvetti A. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension 2000; 35(1 Pt 2): 501–6.

Agnoletti D, Zhang Y, Borghi C, Blacher J, Safar ME. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation. Am J Hypertens 2013; 26(8): 1045–52.

Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363(9426): 2022–31.

Hayoz D, Zappe DH, Meyer MA, Baek I, Kandra A, Joly MP, et al. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen. J Clin Hypertens (Greenwich) 2012; 14(11): 773–8.

Asmar R. Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus. J Renin Angioten-sin Aldosterone Syst 2001; 2 Suppl 2: S8–11.

Agabiti-Rosei E, Porteri E, Rizzoni D. Arterial stiffness, hyper-tension, and rational use of nebivolol. Vasc Health Risk Manag 2009; 5(1): 353–60.

Polónia J, Barbosa L, Silva JA, Bertoquini S. Different patterns of peripheral versus central blood pressure in hypertensive pa-tients treated with β-blockers either with or without vasodila-tor properties or with angiotensin receptor blockers. Blood Press Monit 2010; 15(5): 235–9.

Koumaras C, Tziomalos K, Stavrinou E, Katsiki N, Athyros VG, Mikhailidis DP, et al. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens 2014; 8(2): 74–82.

Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113(9): 1213–25.

Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K. Ef-fects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension. J Cardiovasc Pharmacol 2008; 51(6): 590–5.

Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004; 17(2): 118–23.

Feistritzer HJ, Klug G, Reinstadler SJ, Reindl M, Niess L, Nalbach T, et al. Prognostic Value of Aortic Stiffness in Patients After ST-Elevation Myocardial Infarction. J Am Heart Assoc 2017; 6(9). pii: e005590.

Lüers C, Trippel TD, Seeländer S, Wachter R, Hasenfuss G, Lind-horst R, et al. Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study. J Am Soc Hypertens 2017; 11(5): 303–13.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159–219.

Townsend RR, Rosendorff C, Nichols WW, Edwards DG, Chirinos JA, Fernhall B, et al. American Society of Hypertension posi-tion paper: Central blood pressure waveforms in health and disease. J Am Soc Hypertens 2016;10(1):22–33.

Pini R, Cavallini CM, Palmieri V, Marchionni N, Di Bari M, Devereux RB, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: The ICARe Dicomano Study. J Am Coll Cardiol 2008; 51(25): 2432–9.

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Ar-terial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hyperten-sion (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105–87.

Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruick-shank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using ca-rotid-femoral pulse wave velocity. J Hypertens 2012; 30(3): 445–8.

Shoji T, Nakagomi A, Okada S, Ohno Y, Kobayashi Y. Invasive validation of a novel brachial cuff-based oscillometric device (SphygmoCor XCEL) for measuring central blood pressure. J Hypertens 2017; 35(1): 69–75.